Ishita Active Pharma Ingredients Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 27-12-2024
- Paid Up Capital ₹ 1.21 M
as on 27-12-2024
- Company Age 14 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 7.66 M
as on 27-12-2024
- Revenue 6.18%
(FY 2023)
- Profit -32.71%
(FY 2023)
- Ebitda -318.01%
(FY 2023)
- Net Worth 1.63%
(FY 2023)
- Total Assets -6.39%
(FY 2023)
About Ishita Active Pharma Ingredients
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 1.21 M.
The company currently has active open charges totaling ₹7.66 M.
Rajesh Shah and Nandish Shah serve as directors at the Company.
- CIN/LLPIN
U24239GJ2010PTC060455
- Company No.
060455
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Apr 2010
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Ishita Active Pharma Ingredients Private Limited offer?
Ishita Active Pharma Ingredients Private Limited offers a wide range of products and services, including Packaging Foil, Pharma Foils, Packing Seals, Induction Sealing Wads, Blister Packaging Materials, Printed Blister Foils, Packaging Films & Foils, Lidding Foil.
Who are the key members and board of directors at Ishita Active Pharma Ingredients?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajesh Shah  | Director | 28-Apr-2010 | Current |
| Nandish Shah | Director | 28-Apr-2010 | Current |
Financial Performance of Ishita Active Pharma Ingredients.
Ishita Active Pharma Ingredients Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 6.18% increase. The company also saw a substantial fall in profitability, with a 32.71% decrease in profit. The company's net worth moved up by a moderate rise of 1.63%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ishita Active Pharma Ingredients?
Unlock access to Ishita Active Pharma Ingredients's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 30 May 2018 | ₹7.66 M | Open |
How Many Employees Work at Ishita Active Pharma Ingredients?
Unlock and access historical data on people associated with Ishita Active Pharma Ingredients, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ishita Active Pharma Ingredients, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ishita Active Pharma Ingredients's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
